MXCT
$4.48
Maxcyte
$.01
.22%
MXCT
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  ($0.09)
Revenue:  $10.79 Mil
Wednesday
Aug 9
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when MXCT reports earnings?
Beat
Meet
Miss

Where is MXCT's stock price going from here?
Up
Flat
Down
Stock chart of MXCT
Analysts
Summary of analysts' recommendations for MXCT
Score
Grade
Pivots
Resistance
$4.60
$4.55
$4.51

$4.47

Support
$4.43
$4.38
$4.35
Tweet
Growth
Description
MaxCyte Inc. is a provider of cell-engineering enabling technology and is responsible cell-based therapies. MaxCyte Inc. is headquartered in Gaithersburg, Maryland.